Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 9-(5-o-phosphono-beta-d-arabinofuranosyl)-9h-purin-6-amine
2. Adenine Arabinoside Monophosphate
3. Ara Amp
4. Ara-amp
5. Arabinofuranosyladenine Monophosphate
6. Monophosphate, Adenine Arabinoside
7. Monophosphate, Arabinofuranosyladenine
8. Monophosphate, Vidarabine
9. Phosphate, Vidarabine
10. Vidarabine Monophosphate
1. 29984-33-6
2. Vidarabine Monophosphate
3. Ara-amp
4. Vidarabine Phosphate [usan]
5. Cl-808
6. 9-(5-o-phosphono-beta-d-arabinofuranosyl)adenine
7. Ci-808
8. 9h-purin-6-amine, 9-(5-o-phosphono-beta-d-arabinofuranosyl)-
9. 9-(5-o-phosphono-beta-d-arabinofuranosyl)-9h-purin-6-amine
10. Adenine-9-beta-d-arabinofuranoside-5'-monophosphate
11. Adenine Arabinoside Monophosphate
12. Vidarabine-5'-monophosphate
13. 106xv160tz
14. Arabinosyladenine Monophosphate
15. Adenine Arabinose-5'-phosphate
16. Nsc-127223
17. Araamp
18. 5'-arabinosyladenine Monophosphate
19. 9h-purin-6-amine, 9-(5-o-phosphono-b-d-arabinofuranosyl)-
20. Adenine Arabinoside 5'-monophosphate
21. D-arabinosyladenine 5'-monophosphate
22. Adenine Arabinonucleoside 5'-phosphate
23. [(2r,3s,4s,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl Dihydrogen Phosphate
24. Vidarabine Phosphate (usan)
25. 9h-purin-6-amine,9-(5-o-phosphono-b-d-arabinofuranosyl)-
26. Vidarabinemonophosphate
27. Vidarabine 5'-monophosphate
28. Einecs 249-990-8
29. Nsc 127223
30. 9h-purin-6-amine, 9-(5-o-phosphono-.beta.-d-arabinofuranosyl)-
31. Unii-106xv160tz
32. Nsc127223
33. 9-beta-d-arabinofuranosyladenine 5'-phosphate
34. 9-beta-d-arabinofuranosyladenine Monophosphate
35. Arabino-amp
36. 9-beta-d-arabinofuranosyladenine 5'-monophosphate
37. Mfcd00069723
38. 9-beta-d-arabinofuranosyladenine 5'-(dihydrogen Phosphate)
39. Adenine, 9beta-d-arabinofuranosyl-, 5'-(dihydrogen Phosphate)
40. Schembl144996
41. Chembl1230732
42. Hy-b0277a
43. Adenosine Arabinoside-5'-phosphate
44. Dtxsid401009318
45. Adenine, 9-beta-d-arabinofuranosyl-, 5'-(dihydrogen Phosphate)
46. Bcp10479
47. Zinc2126310
48. Hg1004
49. Vidarabine Phosphate [mart.]
50. Vidarabine Phosphate [who-dd]
51. Akos015915213
52. Ac-5505
53. Am84913
54. ((2r,3s,4s,5r)-5-(6-amino-9h-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl Dihydrogen Phosphate
55. [(2r,3s,4s,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl Dihydrogen Phosphate
56. As-70487
57. Ara-adenosine-5'-monophosphate (ara-amp)
58. Cs-0083442
59. D06299
60. 9-(b-d-arabinofuranosyl)adenine5'-monophosphate
61. 9-(b-d-arabinofuranosyl)adenine 5'-monophosphate
62. 9-beta-d-arabinofuranosyladenine-5'-monophosphate
63. 984a336
64. A820136
65. 9-(.beta.-d-arabinofuranosyl)adenine-5'-phosphate
66. Q6607436
67. W-202244
68. 9-beta-d-arabinofuranosyl-adenine-5'-monophosphate
69. 9h-purin-6-amine, 9-(5-o-phosphono-b-d-arabinofuranosyl)-;
70. 9-.beta.-d-arabinofuranosyladenine 5'-(dihydrogen Phosphate)
71. {[(2r,3s,4s,5r)-5-(6-amino-9h-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic Acid
72. A5o
| Molecular Weight | 347.22 g/mol |
|---|---|
| Molecular Formula | C10H14N5O7P |
| XLogP3 | -3.5 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 11 |
| Rotatable Bond Count | 4 |
| Exact Mass | 347.06308480 g/mol |
| Monoisotopic Mass | 347.06308480 g/mol |
| Topological Polar Surface Area | 186 Ų |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Complexity | 481 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antimetabolites
Drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways. (From AMA Drug Evaluations Annual, 1994, p2033) (See all compounds classified as Antimetabolites.)
Antiviral Agents
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)
ABOUT THIS PAGE
A Vidarabine Monophosphate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Vidarabine Monophosphate, including repackagers and relabelers. The FDA regulates Vidarabine Monophosphate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Vidarabine Monophosphate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Vidarabine Monophosphate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Vidarabine Monophosphate supplier is an individual or a company that provides Vidarabine Monophosphate active pharmaceutical ingredient (API) or Vidarabine Monophosphate finished formulations upon request. The Vidarabine Monophosphate suppliers may include Vidarabine Monophosphate API manufacturers, exporters, distributors and traders.
click here to find a list of Vidarabine Monophosphate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Vidarabine Monophosphate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Vidarabine Monophosphate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Vidarabine Monophosphate GMP manufacturer or Vidarabine Monophosphate GMP API supplier for your needs.
A Vidarabine Monophosphate CoA (Certificate of Analysis) is a formal document that attests to Vidarabine Monophosphate's compliance with Vidarabine Monophosphate specifications and serves as a tool for batch-level quality control.
Vidarabine Monophosphate CoA mostly includes findings from lab analyses of a specific batch. For each Vidarabine Monophosphate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Vidarabine Monophosphate may be tested according to a variety of international standards, such as European Pharmacopoeia (Vidarabine Monophosphate EP), Vidarabine Monophosphate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Vidarabine Monophosphate USP).
LOOKING FOR A SUPPLIER?
